Dominant mutations in ATP1A1, encoding the alpha-1 isoform of the Na<sup>+</sup> /K<sup>+</sup> -ATPase, have been recently reported to cause an axonal to intermediate type of Charcot-Marie-Tooth disease (ie, CMT2DD) and a syndrome with hypomagnesemia, intractable seizures and severe intellectual disability.